NFKB1 and autoimmune disease: A novel dsDNA-mediated NF-κB activation pathway facilitated through a STING-TRAF6-TBK1 axis suggests a target for therapeutic interventions to avert dsDNA-mediated cytokine and type I IFN autoimmune disease 15.